After pumps, Bata stores to provide cash withdrawal 2016-12-052016-12-05 | Sanjay Kumar The story has been withdrawn by the company. RELATEDMetro Brands to pursue multi-brand, multi-channel strategy Mumbai-based footwear retailer Metro Brands Ltd plans to pursue a multi-channel, multi-brand strategy for growth in coming quarters, the company…Spencer's Bets Big on Key Regions; Plans Store Blitz As Kolkata-based retailer Spencer's Retail charts its recovery, the company has turned its attention to aggressively expanding its presence in…Renaissance Global retail sales up 23% YoY in Jul-Sep Mumbai-based jewellery company Renaissance Global Limited (RGL) posted a strong 23% year-on-year growth in its direct-to-consumer (D2C) business revenue to…DB Realty Divests Rustomjee Crown for Rs 231 Crore DB Realty Limited has executed a share purchase agreement to sell its entire stake in wholly-owned subsidiary Real Gem Buildtech…Shift from Offline to Online Plateauing - Shoppers Stop Leading omni-channel retailer Shoppers Stop registered a steady 4% growth in total sales for the third quarter of FY24, despite…Titan Records 21% Growth in Q2 FY2023-24, Led by Strong Performance Across Segments Titan Company Limited, India's leading consumer lifestyle company and part of the Tata Group, today reported strong second quarter results…Will India's new tariffs on PCs, laptops and servers work? India imposed import tariffs on PCs, laptops and servers recently to spur local manufacturing and lower security threats from China,…Quess Corp Reports Strong Q2 FY2024 Results Bengaluru-based business services provider Quess Corp reported robust top-line growth along with significant improvements in profitability. Quess Corp's total revenue…In The Era Of Momentum Investing, Passive Is Where The Money Is An analysis of the fund flows this year so far shows that a whopping 42% of FII's total inflows into…Rising generic threat in India not reflected in Pharma valuations - Kotak Institutional A new report by Kotak Institutional Equities suggests that investors may be underestimating the threat posed by generic drugs to…